ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bile acids promote the development of HCC by activating inflammasome

Chen, Wenbo; Ding, Ming; Ji, Liyan; Yao, Jingjing; Guo, Yajuan; Yan, Wenxin; Yu, Shaofang; Shen, Qinghong; Huang, Min; Zheng, Yaqiu; Lin, Yuefang; Wang, Ying; Liu, Zhongqiu*; Lu, Linlin*; Jin, Xin*广州中医药大学; 1
Hepatology Communications2023-9DOI: 10.1097/HC9.0000000000000217
1被引7阅读
引用收藏
分享

摘要

Background:Hepatocellular carcinoma (HCC) is associated with chronic inflammation caused by different factors; especially, the interaction of inflammatory pathways and bile acids (BAs) can affect hepatocyte proliferation, death, and regeneration, but whether BAs promote HCC progression through inflammatory pathways and the mechanisms is still unclear. Methods and results:By examining cancer and tumor-adjacent tissue BA levels and genes associated with BA homeostasis in 37 HCC patients, we found that total bile acids (TBAs) were decreased by 36% and varying degrees of changes in factors regulating BA homeostasis (p < 0.05). In addition, we found that BA homeostasis was disturbed in diethylnitrosamine-induced HCC mouse models, and TBA was correlated with inflammasome activation during HCC progression (6-24 W) (p < 0.05). Similarly, the inflammasome and chenodeoxycholic acid (CDCA) content were suppressed in cholestasis model mice (Mrp2-deficient mice) (p < 0.05). In vitro, CDCA significantly promoted the malignant transformation of hepatocytes (p < 0.001), activated the inflammasome by triggering the release of mitochondrial reactive oxygen species and mitochondrial DNA, and ultimately induced pyroptosis. Furthermore, we found that CDCA has a targeted binding effect with HO-1 through molecular docking and Cellular Thermal Shift Assay experiments. Conclusions:In conclusion, we found that CDCA can trigger the excessive accumulation of mitochondrial reactive oxygen species by targeting HO-1 to promote the activation of the inflammasome and ultimately promote the progression of HCC. Our study provides a novel mechanism by which BAs promote HCC by activating the inflammasome and establishes the important role of BA homeostasis imbalance in the progression of HCC from the aspect of inflammation.

学科与关键词

关键词
NLRP3 INFLAMMASOMESIGNALING PATHWAYSOXIDATIVE STRESSMICEHEPATOCARCINOGENESISMITOCHONDRIAMETABOLISMRESISTANCEROS
相关
加载中…
  • Glycocholic acid aggravates liver fibrosis by promoting the up-regulation of connective tissue growth factor in hepatocytes
    Yuan, Zihang; Wang, Jie; Zhang, Haoran; Chai, Yuanyuan; Xu, Yunxia; Miao, Yingying; Yuan, Ziqiao; Zhang, Luyong; Jiang, Zhenzhou*; Yu, Qinwei*Cellular Signalling, 2023, 101: 110508.被引 3
  • Inhibition of NLRP3-mediated crosstalk between hepatocytes and liver macrophages by geniposidic acid alleviates cholestatic liver inflammatory injury
    Song, Meng; Chen, Zijun; Qiu, Ruian; Zhi, Tingwei; Xie, Wenmin; Zhou, Yingya; Luo, Nachuan; Chen, Fuqian; Liu, Fang; Shen, Chuangpeng; Lin, Sheng*; Zhang, Fengxue*; Gao, Yong*; Liu, Changhui*Redox Biology, 2022, 55: 102404.被引 9
  • Role of gasdermin family proteins in the occurrence and progression of hepatocellular carcinoma
    Miao, Yandong*; Chen, Yonggang; Mi, DenghaiHeliyon, 2022, 8(10): e11035.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Hepatology Communications
发表日期
2023-09
卷期
第 7 卷, 第 9 期
页码
e0217
DOI
10.1097/HC9.0000000000000217
成果收录
SCIE
资助标注
Guangdong Key Laboratory for Translational Cancer Research of Chinese Medicine [2018B030322011]; National Natural Science Foundation of China [81720108033, 82022074]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]

作者

  • C

    Chen, Wenbo (第一作者)

    guangzhou univ chinese med

  • D

    Ding, Ming

    guangzhou univ chinese med

查看全部 15 位作者收起作者
  • J

    Ji, Liyan

    guangzhou univ chinese med

  • Y

    Yao, Jingjing

    guangzhou univ chinese med

  • G

    Guo, Yajuan

    guangzhou univ chinese med

  • Y

    Yan, Wenxin

    guangzhou univ chinese med

  • Y

    Yu, Shaofang

    guangzhou univ chinese med

  • S

    Shen, Qinghong

    guangzhou univ chinese med

  • H

    Huang, Min

    guangzhou univ chinese med

  • Z

    Zheng, Yaqiu

    guangzhou univ chinese med

  • L

    Lin, Yuefang

    guangzhou univ chinese med

  • W

    Wang, Ying

    guangzhou univ chinese med

  • L

    Liu, Zhongqiu (通讯)

    guangzhou univ chinese med

  • L

    Lu, Linlin (通讯)

    guangzhou univ chinese med

  • J

    Jin, Xin (通讯)

    1 · guangzhou univ chinese med · guangzhou univ tradit chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417